India’s Nutraceuticals Market - In Wellness, Only the Focused Will Win!

Inside India’s $18B Nutraceutical Revolution: From Chyawanprash to Collagen, How Precision Wellness is Redefining the Rules of Consumption

Eximius Ventures, Shriya Bhandari, Preeti Sampat, and Shubham Titare

May 26, 2025

Hi there!

This week on Eximius Echo, we decode a sector that’s long been hyped as the next big consumption wave - India’s Nutraceuticals Market. Once confined to dusty shelves of chyawanprash jars and herbal capsules, the category is undergoing a silent but significant transformation. Collagen powders, energy pouches, gut-health gummies, and buccal sprays are no longer niche, they’re signals of a shift from traditional wellness to precision nutrition.

It’s not just Ayurveda rebranded, it’s Ayurveda reimagined. Powered by rising preventive health awareness, lifestyle diseases, and Gen Z’s obsession with performance and longevity, this $18B+ market is expanding fast. But growth doesn’t equal gold. The real game? Retention, ritual, and ruthless focus.

If you’re new here, Eximius is a pre-seed VC fund backing bold ideas in fintech, AI/SaaS, and consumer tech. We use this newsletter to share insights, trends, and ideas from the sectors we’re passionate about. Let’s dive in.

The Indian nutraceuticals sector is often painted as the next big consumption wave. From chyawanprash to collagen powders, we’ve come a long way. But is this a “massive TAM” story? Or a game of sharper focus, better retention, and execution?

Here’s a grounded look at where the market stands, where capital should flow, and where it shouldn’t.

From Ayurveda to Functional Wellness: The Market is Expanding, But Fragmented

Regulated by FSSAI, CDSCO, Ministry of AYUSH.
Evolving from Ayurveda legacy to new-age formats (gummies, strips, pouches).
Online-first but offline channels (Apollo, H&G, modern trade) remain critical for scale.

The Demand is Real, Retention is Not

Health spending grew 11% in 2023; preventive care jumped 15%.
20M+ Indians consume fortified foods regularly.
65% + of Gen Z/Millennial supplement purchases happen online.
Rising lifestyle disorders: 1 in 3 urban Indians has metabolic syndrome.

But retention is weak. Most D2C supplement brands struggle to hold >20% monthly repeats. Consumers experiment, but loyalty is rare unless taste, convenience, AND perceived benefit align.

Format Wars: Bioavailability is Basic, Use Case Wins

High bioavailability is now hygiene. The game is moving to habit formation and specific use-cases.

The Real Challenges: Focus, Retention, and GTM Weakness

Competitor Landscape: Crowded, but Gaps Remain

Despite the noise, few brands have cracked category leadership with scale and repeat usage.

The market isn’t short of products, it’s short of habit-forming, repeat-worthy brands. The whitespace lies in focused use-cases (energy, female health, stress recovery) with formats that deliver tangible results and integrate into daily routines.

Why Most Brands Burn & Few Will Scale

Regulatory Ambiguity: 15% of new products hit FSSAI compliance hurdles.
High R&D Cost: Nutraceutical R&D is 2x FMCG; premium ingredients, bioavailability testing add up.
Burn Risk: High CAC (₹700–₹1,200) with poor retention = unsustainable without clear PMF.
Trust Deficit: Overhyped claims, low transparency. Brands must invest in education & efficacy proof.

Success will depend on scientific credibility, sharp use-case fit, and ruthless retention strategies via cross-sell and upsell opportunities.

Bottom Line: Precision Beats Spray & Pray

The market is real, but it’s far from limitless. It’s a mid-sized, highly competitive sector where scaling requires more than just a trendy format. Success hinges on aligning bioavailability, specific use cases, and consumer-friendly formats; anything less will get drowned in noise. Brands must solve retention early, with clear LTV/CAC models baked into Day 1.

The path to ₹100 Cr+ isn’t through endless SKU proliferation but through building 5-10 high-velocity hero products.

Founding teams with deep marketing, GTM, and retention expertise, not just product enthusiasm, will drive outcomes. Packaging and positioning will be critical to cut through consumer fatigue. In this category, winning is less about “innovation theatre” and more about precision, habit formation, and ruthless focus on repeat behaviour. This isn’t a spray-and-pray game anymore.

The opportunity exists, but so does the execution risk. Smart capital will back brands with sharp category focus, superior retention economics, and teams that understand how to build consumption rituals. The next wave of winners will be those who deliver real outcomes, own specific use-cases, and scale not through noise but through disciplined execution.

We're looking to back brands that operate in clearly defined, high-intent categories; energy, recovery, women’s health, or gut health with measurable outcomes that users can feel. Formats must be meaningfully better than what they replace, faster, more portable, or habit-forming, not just new for novelty’s sake. Retention needs to be designed from Day 1 through product efficacy, smart post-purchase journeys, and repeat behaviour triggers. We’re not interested in SKU sprawl; brands should go deep, not wide, with 5–10 hero products that scale. The focus should be on building rituals, not catalogues. Ultimately, we look for execution teams who can turn health utility into lifestyle behaviour.

If you are looking to build in this space, we would love to chat! Please reach out to us at pitches@eximiusvc.com.